期刊
AIDS RESEARCH AND HUMAN RETROVIRUSES
卷 28, 期 7, 页码 641-648出版社
MARY ANN LIEBERT, INC
DOI: 10.1089/aid.2011.0239
关键词
-
资金
- Global HIV Vaccine Enterprise
- OCTAVE Project
- Bill and Melinda Gates Foundation
- NIH Office for AIDS Research
Well-defined correlates of protective immunity are an essential component of rational vaccine development. Despite years of basic science and three HIV vaccine efficacy trials, correlates of immunological protection from HIV infection remain undefined. In December 2010, a meeting of scientists engaged in basic and translational work toward developing HIV-1 vaccines was convened. The goal of this meeting was to discuss current opportunities and optimal approaches for defining correlates of protection, both for ongoing and future HIV-1 vaccine candidates; specific efforts were made to engage young scientists. We discuss here the highlights from the meeting regarding the progress made and the way forward for a protective HIV-1 vaccine.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据